It is clear that only the University of Buffalo is doing CCSVI treatment research which is the only type of research we need at this time. Direct-MS will match dollar for dollar, up to $150,000, funds donated to the PREMISE trial in the next 2 months. CCSVI treatment will not be made available until such trial data are available.